Skip to content

Mata Charokopou

    • 3h-indexImpact measure calculated using publication and citation counts. Updated daily.
    • 24CitationsNumber of citations received by Mata's publications. Updated daily.

    Other IDs

    Co-authors (30)

    Publications (5)

    • A discrete-choice experiment to elicit preferences of patients with epilepsy for self-management programs

      • Atkinson-Clark E
      • Charokopou M
      • Van Osselaer N
      • et al.
      N/AReaders
      0Citations
      Get full text
    • Cost-effectiveness analysis of exenatide once-weekly versus dulaglutide, liraglutide, and lixisenatide for the treatment of type 2 diabetes mellitus: an analysis from the UK NHS perspective

      • Chuang L
      • Verheggen B
      • Charokopou M
      • et al.
      N/AReaders
      1Citations
      Get full text
    • Methods applied in cost-effectiveness models for treatment strategies in type 2 diabetes mellitus and their use in Health Technology Assessments: A systematic review of the literature from 2008 to 2013

      • Charokopou M
      • Sabater F
      • Townsend R
      • et al.
      N/AReaders
      3Citations
      Get full text
    • Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System Perspective

      • Charokopou M
      • McEwan P
      • Lister S
      • et al.
      N/AReaders
      7Citations
      Get full text
    • The cost-effectiveness of dapagliflozin versus sulfonylurea as an add-on to metformin in the treatment of Type 2 diabetes mellitus

      • Charokopou M
      • McEwan P
      • Lister S
      • et al.
      N/AReaders
      4Citations
      Get full text